Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-06-28
2011-06-28
Audet, Maury (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S183000, C514S309000, C514S310000, C514S319000, C514S331000, C424S001690
Reexamination Certificate
active
07968511
ABSTRACT:
The subject invention provides a method of treating a subject afflicted with a form of multiple sclerosis comprising periodically administering to the subject an amount of glatiramer acetate and an amount of mitoxantrone, wherein the amounts when taken together are effective to alleviate a symptom of the form of multiple sclerosis in the subject so as to thereby treat the subject. The subject invention also provides a package comprising glatiramer acetate, mitoxantrone and instructions for use of the together to alleviate a symptom of a form of multiple sclerosis in a subject. Additionally, the subject invention provides a pharmaceutical composition comprising an amount of glatiramer acetate and an amount of mitoxantrone, wherein the amounts when taken together are effective to alleviate a symptom of a form of multiple sclerosis in a subject. The subject invention further provides a pharmaceutical combination comprising separate dosage forms of an amount of glatiramer acetate and an amount of mitoxantrone, which combination is useful to alleviate a symptom of a form of multiple sclerosis in a subject.
REFERENCES:
patent: 4617319 (1986-10-01), Kerwar et al.
patent: 6214791 (2001-04-01), Arnon et al.
patent: 6531464 (2003-03-01), Szabo et al.
International Search Report issued by the International Searching Authority on Jan. 31, 2005 in connection with International Application No. PCT/US2004/015225.
Written Opinion Of The International Searching Authority issued by the International Searching Authority on Jan. 31, 2005 in connection with International Application No. PCT/US2004/015225.
Audet Maury
Cooper & Dunham LLP
Teva Pharmaceutical Industries Ltd.
White John P.
LandOfFree
Combination therapy with glatiramer acetate and mitoxantrone... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapy with glatiramer acetate and mitoxantrone..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy with glatiramer acetate and mitoxantrone... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2635710